Moderna Shares Nearly Post Worst Session After Vaccine Data Leak
A leak of data for Moderna and Merck's cancer-vaccine candidate triggered selling in Moderna shares. The companies were set to present an expanded dataset.
A leak of data for Moderna and Merck's cancer-vaccine candidate triggered selling in Moderna shares. The companies were set to present an expanded dataset.